572 / 1631
RELEVANCE Study Design
(Rituximab and LEnalidomide versus Any ChEmotherapy)
1
st
line
FL
N=1000
R
R
2
R + Chemo
R
2
Maintenance
Rituximab Maint.
•
R+Chemo:
•
Investigator’s choice of R-CHOP, R-CVP, BR
•
Lenalidomide 20mg for 6 cycles, then 10mg if CR